STTK - Total Utang marang Modal Shattuck Labs
Shattuck Labs, Inc. (STTK) is developing a unique environment in the immuno-oncology sector, utilizing the ARC platform to create patent-protected proteins. Market price action based on the individual debt-to-equity ratio is 0.01. The firm's resilience depends on the safety of new developments and the volume of research funding. Currently, Shattuck Labs, Inc. (STTK) is gradually depleting its existing capital to finance costly clinical trials.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_STTK_-_Shattuck-Labs-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "STTK (Shattuck Labs) riwayat Total Utang marang Modal saka 04.07.2022 nganti 29.10.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan Shattuck Labs, Inc.
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Shattuck Labs, Inc.|STTK - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Shattuck Labs Inc|STTK - Gunggung utang perusahaan|Utang marang nilai buku Shattuck Labs|STTK - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Shattuck Labs|Likuiditas cepet shattucklabs.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:Shattuck Labs, Inc.
For the disciplined immuno-oncology biotech Shattuck Labs, Inc. (STTK), the debt-to-equity ratio trend reflects the efficiency of management's resource allocation when funding clinical trials. This indicator is calculated as the sum of all liabilities divided by net assets, allowing investors to assess the degree of leverage and the risk of a price decline should operating cash flow contract.
Analisis pesaing Shattuck Labs, Inc.
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA - Utang marang Ekuitas|Koefisien Total Utang marang Modal Savara Pharma SVRA|RIGL: Total Utang marang Modal|anaptysbio.com - Rasio Kabeh Utang marang Dana Pribadi|ATXS (Astria Therapeutics, Inc.) - Total Utang marang Modal|Total Utang marang Modal enGene Holdings Inc|Rasio Total Utang marang Ekuitas RAPT (RAPT Therapeutics, Inc.)|Utang Agregat marang Modal JBIO|Aclaris Therapeutics - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal KYTX (kyvernatx.com)|TLSA: Rasio Total Utang marang Ekuitas|CABA - Total Utang marang Modal|VTYX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Theratechnologies, Inc|Utang marang Ekuitas Avalo Therapeutics, Inc|Total Utang marang Modal eledon.com|Rasio Total Utang marang Ekuitas AGEN (Agenus Inc.)|CLYM (Climb Bio Inc.) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Zura Bio Limited ZURA|aTyr Pharmaceuticals - Utang marang Ekuitas|Adagene Corp - Total Utang marang Modal|IMA - Total Utang marang Modal|EQ: Total Utang marang Modal|CNTB (Connect Biopharma Holdings Limited) - Utang marang Ekuitas|Utang marang Ekuitas Immunic Therapeutics|Atara Biotherapeutics Inc (ATRA) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas IFRX (InflaRx N.V.)|XFOR (x4pharma.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ACET (Adicet Bio, Inc.)|Koefisien Total Utang marang Modal Celularity Inc (CELU)|INMB - Utang marang Ekuitas|BRNS (Barinthus Biotherapeutics Corp) - Rasio Utang marang Ekuitas|KZR: Total Utang marang Modal|Rasio Total Utang marang Ekuitas sabbiotherapeutics.com|Rasio Total Utang marang Ekuitas AKTX|Enlivex Therapeutics, Ltd. (ENLV) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Q32 Bio Inc. (QTTB)|Koefisien Total Utang marang Modal GeoVax Corp|Edesa Biotech, Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal IBIO (ibioinc.com)|CARM: Rasio Total Utang marang Ekuitas|XTL Biopharmaceuticals Ltd - Utang Agregat marang Modal|boltbio.com (BOLT) - Utang marang Ekuitas|HCW Biologics (HCWB) - Total Utang marang Modal|Utang marang Ekuitas Aptevo Therapeutics, Inc.|AIM ImmunoTech, Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ADTX|GRI (GRI Bio Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal XRTX (XORTX)|Total Utang marang Modal Vyome Therapeutics HIND|REVB - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi INDP (indaptusrx.com)|Scinai Immunotherapeutics Ltd. (SCNI) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas CalciMedica|AFMD (Affimed NV) - Total Utang marang Modal|Total Utang marang Modal Allakos Therapeutics|Rasio Total Utang marang Ekuitas HOOK (HOOKIPA Pharma Inc.)|IGMS (igmbio.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ITOS (iTeos Therapeutics, Inc.)|Koefisien Total Utang marang Modal Ocean Biomedical Inc (OCEA)|TCBP - Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Rasio Total Utang marang Ekuitas